S032 Challenging Adult and Pediatric Autoimmune Connective Tissue Disease Cases: Pearls for Diagnosis and Management
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Using clinical cases, classic and atypical presentations of cutaneous manifestations of autoimmune connective tissue diseases will be emphasized. This session will offer practical tips for diagnosis, appropriate evaluation, and advanced therapeutic management of both adult and pediatric patients with connective tissue diseases affecting the skin. Audience self-assessment will be encouraged through image review, and a case-based approach will be utilized to highlight relevance for the dermatology trainee or experienced clinician. Cases discussed will include those focusing on dermatomyositis, cutaneous lupus erythematosus, systemic sclerosis, eosinophilic fasciitis, and morphea, amongst others.
LEARNING OBJECTIVES
Identify and diagnose classic and atypical presentations of cutaneous manifestations of autoimmune connective tissue diseases in both adults and children.
Select management options for skin involvement in complex connective tissue diseases based on the best available evidence from the literature.
SCHEDULE
6:00 PM
Challenging Adult and Pediatric Autoimmune Connective Tissue Disease Cases
SPEAKERS
Rochelle Castillo, MD, MS
Gabriela Andrea Cobos, MD, FAAD
John R. Edminister, MD, FAAD
Alisa Femia, MD, FAAD
Kimberly V. Hashemi, MD, FAAD
Zachary Holcomb, MD, FAAD
Yoo Jung Kim, MD, FAAD
Avery H LaChance, MPH, MD, FAAD
Christina Lam, MD, FAAD
Sarah Lonowski, MD, MBA, FAAD
Michelle Min, MD, MSc, FAAD
Neda Shahriari, MD, FAAD
Leila Shayegan, MD, FAAD
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
SPEAKER DISCLOSURES
Rochelle Castillo, MD, MS
No financial relationships exist with ineligible companies.
Gabriela Andrea Cobos, MD, FAAD
AbbVie – Speaker(Fees); Biogen – Investigator(Honoraria); Bristol Myers Squibb – Speaker/Faculty Education(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria); Dermira/Lilly – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Fees); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Fees); UCB – Advisory Board(Honoraria);
John R. Edminister, MD, FAAD
Priovant Therapeutics – Consultant (1099 relationship)(Fees);
Alisa Femia, MD, FAAD
No financial relationships exist with ineligible companies.
Kimberly V. Hashemi, MD, FAAD
No financial relationships exist with ineligible companies.
Zachary Holcomb, MD, FAAD
No financial relationships exist with ineligible companies.
Yoo Jung Kim, MD, FAAD
No financial relationships exist with ineligible companies.
Avery H LaChance, MPH, MD, FAAD
Guidepoint Global, LLC – Consultant (1099 relationship)(Fees); Johnson & Johnson Consumer, Inc. – Advisory Board(Honoraria); MEDACorp – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); TD Cowen – Speaker(Honoraria);
Christina Lam, MD, FAAD
Biogen – Consultant (1099 relationship)(Fees), Investigator(Fees);
Sarah Lonowski, MD, MBA, FAAD
AstraZeneca – Investigator(Grants/Research Funding); Bristol Myers Squibb – Other(Other Financial Benefit); Eli Lilly – Investigator(Grants/Research Funding);
Michelle Min, MD, MSc, FAAD
Amgen – Investigator(Grants/Research Funding); AstraZeneca – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Other Financial Benefit), Investigator(Grants/Research Funding); McGraw-Hill Companies – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Investigator(Grants/Research Funding);
Neda Shahriari, MD, FAAD
No financial relationships exist with ineligible companies.
Leila Shayegan, MD, FAAD
No financial relationships exist with ineligible companies.
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);